Dyadic Neurofeedback for Development of Healthy Emotion Regulation in Youth
NCT ID: NCT05472545
Last Updated: 2025-08-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
210 participants
INTERVENTIONAL
2023-03-13
2025-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dyadic Neurofeedback for Emotion Regulation in Youth With Maternal Adversity
NCT04964726
Parent-Adolescent Training on Neurofeedback and Synchrony
NCT03929263
Augmented Mindfulness Training for Resilience in Early Life
NCT04053582
Neurobiological Mechanisms of Stress in Youth With Chronic Widespread Pain
NCT04488757
Mothers With a History of Depression and Their 10-14 Year Old Daughters
NCT01129752
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Neurofeedback Group
Mothers of adolescent participants will view real-time fMRI neurofeedback representing activity in their daughter's anterior insula during an emotion discussion task. Activity will be presented as a colored bar of moving height, and mothers will be instructed to attempt to downregulate the activity through what they say to their daughter.
Neurofeedback
Real-time functional magnetic resonance imaging dyadic neurofeedback
Control Group
The paradigm for the control condition will be identical to that of the experimental condition except that no neurofeedback will be presented. Participants in the control group will be told that we would like to see if the mother can regulate her daughter's brain activity through supportive statements.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neurofeedback
Real-time functional magnetic resonance imaging dyadic neurofeedback
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Sufficient English fluency to complete tasks
* Co-residing at least 4 days per week
* Primary caregiver for more than 50% of child's lifespan
* History of at least two adverse childhood experiences
* Biological parent of adolescent participant
* Eligible for fMRI
* Body mass index between 16 and 40 (inclusive)
* Age 14-17 years
Exclusion Criteria
* Neurodevelopmental delay
* Medications influencing fMRI
* Medical conditions influencing fMRI
14 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oklahoma State University Center for Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kara Kerr
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kara L Kerr, PhD
Role: PRINCIPAL_INVESTIGATOR
Oklahoma State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hardesty Center for Clinical Research and Neuroscience
Tulsa, Oklahoma, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022029-Hardesty
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.